• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Foxp3+调节性T细胞:受到审视的自私性

Foxp3+ regulatory T cells: selfishness under scrutiny.

作者信息

Stephens Geoffrey L, Shevach Ethan M

机构信息

Cellular Immunology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Immunity. 2007 Sep;27(3):417-9. doi: 10.1016/j.immuni.2007.08.008.

DOI:10.1016/j.immuni.2007.08.008
PMID:17892850
Abstract

The Foxp3+ T cell lineage is thought to arise from self-specific precursors during development. By using a unique mouse model, Pacholczyk et al. (2007) present compelling evidence that self-specific cells are exceedingly rare among Foxp3(-) and, surprisingly, Foxp3+ subsets.

摘要

Foxp3+ T细胞谱系被认为在发育过程中源自自身特异性前体细胞。通过使用一种独特的小鼠模型,帕乔尔茨克等人(2007年)提供了令人信服的证据,表明自身特异性细胞在Foxp3(-)以及令人惊讶的是在Foxp3+亚群中极其罕见。

相似文献

1
Foxp3+ regulatory T cells: selfishness under scrutiny.Foxp3+调节性T细胞:受到审视的自私性
Immunity. 2007 Sep;27(3):417-9. doi: 10.1016/j.immuni.2007.08.008.
2
Foxp3 and Aire in thymus-generated Treg cells: a link in self-tolerance.胸腺生成的调节性T细胞中的Foxp3和Aire:自身耐受的一个环节。
Nat Immunol. 2007 Apr;8(4):333-4. doi: 10.1038/ni0407-333.
3
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.一种适应性良好的调节机制:调节性T细胞的发育与叉头框家族转录因子Foxp3
Nat Immunol. 2005 Apr;6(4):331-7. doi: 10.1038/ni1179.
4
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.CD4+Foxp3+调节性T细胞在自身免疫控制中的作用:体内的真相。
Curr Opin Immunol. 2008 Dec;20(6):655-62. doi: 10.1016/j.coi.2008.09.006. Epub 2008 Oct 28.
5
CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.由与肠道上皮细胞的抗原驱动相互作用诱导的CD4+Foxp3+调节性T细胞扩增,与局部树突状细胞无关。
Gut. 2009 Feb;58(2):211-9. doi: 10.1136/gut.2008.151720. Epub 2008 Oct 2.
6
Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.小鼠和人类中Foxp3(+) γδ T细胞的鉴定与特征分析
Immunol Lett. 2009 Aug 15;125(2):105-13. doi: 10.1016/j.imlet.2009.06.005. Epub 2009 Jun 17.
7
Maintaining immunological tolerance with Foxp3.利用Foxp3维持免疫耐受。
Cell Res. 2007 Nov;17(11):904-18. doi: 10.1038/cr.2007.84.
8
Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.在小鼠模型中,肾移植排斥反应进展过程中表达Foxp3的调节性T细胞浸润减少。
Transpl Immunol. 2008 May;19(2):93-102. doi: 10.1016/j.trim.2008.03.004. Epub 2008 Apr 28.
9
Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.异种猪胸腺移植物中小鼠CD4(+)CD25(+)Foxp3(+)调节性T细胞的发育
Transpl Immunol. 2009 Jan;20(3):180-5. doi: 10.1016/j.trim.2008.09.006. Epub 2008 Oct 7.
10
Toward standardization of Foxp3+ regulatory T-cell measurement in clinical settings.迈向临床环境中Foxp3 +调节性T细胞测量的标准化。
Cytometry B Clin Cytom. 2009 Mar;76(2):67-8. doi: 10.1002/cyto.b.20471.

引用本文的文献

1
TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and Search for Small Molecule Binders.肿瘤坏死因子Ⅱ型受体作为治疗癌症、自身免疫性疾病和移植物抗宿主病的新兴药物靶点:当前观点及小分子结合剂的探索
Front Immunol. 2018 Jun 18;9:1382. doi: 10.3389/fimmu.2018.01382. eCollection 2018.
2
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.TNF 受体 II 靶向药物对调节性 T 细胞活性的调节作用。
Front Immunol. 2018 Mar 26;9:594. doi: 10.3389/fimmu.2018.00594. eCollection 2018.
3
Pathological conditions re-shape physiological Tregs into pathological Tregs.
病理状况将生理性调节性T细胞重塑为病理性调节性T细胞。
Burns Trauma. 2015 Dec;3(1). doi: 10.1186/s41038-015-0001-0. Epub 2015 May 28.
4
Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.调节性T细胞的调控与基于抗原特异性细胞毒性T淋巴细胞的肿瘤免疫疗法
Immunology. 2015 Feb;144(2):186-96. doi: 10.1111/imm.12387.
5
Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells.表观遗传酶是CD4(+)CD25(+/高)Foxp3(+)调节性T细胞的治疗靶点。
Transl Res. 2015 Jan;165(1):221-40. doi: 10.1016/j.trsl.2014.08.001. Epub 2014 Aug 15.
6
Regulatory T cells and Atherosclerosis.调节性T细胞与动脉粥样硬化
J Clin Exp Cardiolog. 2012 Oct 8;2012(Suppl 12):2. doi: 10.4172/2155-9880.S12-002.
7
Immune response to lipoproteins in atherosclerosis.动脉粥样硬化中对脂蛋白的免疫反应。
Cholesterol. 2012;2012:571846. doi: 10.1155/2012/571846. Epub 2012 Aug 23.
8
Optimal population of FoxP3+ T cells in tumors requires an antigen priming-dependent trafficking receptor switch.肿瘤中 FoxP3+ T 细胞的最佳群体需要抗原引发依赖性归巢受体转换。
PLoS One. 2012;7(1):e30793. doi: 10.1371/journal.pone.0030793. Epub 2012 Jan 23.
9
Innate and adaptive immunity in inflammatory bowel disease.炎症性肠病中的先天免疫和适应性免疫。
World J Gastroenterol. 2011 Jul 21;17(27):3178-83. doi: 10.3748/wjg.v17.i27.3178.
10
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.动脉粥样硬化中的适应性免疫:机制与未来治疗靶点。
Nat Rev Cardiol. 2011 Jun;8(6):348-58. doi: 10.1038/nrcardio.2011.62. Epub 2011 Apr 19.